ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository ("Registry")

被引:0
作者
Cecchi, Irene [1 ,2 ,3 ]
Radin, Massimo [1 ,2 ,3 ]
Foddai, Silvia Grazietta [1 ,2 ,3 ]
Barinotti, Alice [1 ,2 ,3 ]
Andrade, Danieli [4 ]
Tektonidou, Maria G. [5 ]
Pengo, Vittorio [6 ]
Ruiz-Irastorza, Guillermo [7 ]
Belmont, H. Michael [8 ]
Pedrera, Chary Lopez [9 ]
Fortin, Paul R. [10 ]
Gerosa, Maria [11 ]
de Jesus, Guilherme [12 ]
Atsumi, Tatsuya [13 ]
Ji, Lanlan [14 ]
Efthymiou, Maria [15 ]
Branch, D. Ware [16 ,17 ]
Nalli, Cecilia [18 ]
Rodriguez-Almaraz, Esther [19 ]
Petri, Michelle [20 ]
Cervera, Ricard [21 ]
Knight, Jason S. [22 ]
Artim-Esen, Bahar [23 ]
Willis, Rohan [24 ]
Bertolaccini, Maria Laura [25 ]
Cohen, Hannah [15 ]
Erkan, Doruk [26 ]
Sciascia, Savino [1 ,2 ,3 ]
机构
[1] San Giovanni Bosco Hub Hosp, Univ Ctr Excellence Nephrol Rheumatol & Rare Dis, ERK Net ERN Reconnect & RITA ERN, Nephrol & Dialysis Unit, I-10154 Turin, Italy
[2] San Giovanni Bosco Hub Hosp, Ctr Immunorheumatol & Rare Dis CMID, Coordinating Ctr Interreg Network Rare Dis Piedmon, I-10154 Turin, Italy
[3] Univ Turin, Dept Clin & Biol Sci, Turin, Italy
[4] Univ Sao Paulo, Sao Paulo, Brazil
[5] Natl & Kapodistrian Univ Athens, Athens, Greece
[6] Univ Padua, Padua, Italy
[7] Univ Basque Country, Biobizkaia Hlth Res Inst, Autoinmune Dis Res Unit, Baracaldo, Spain
[8] NYU, Langone Med Ctr, New York, NY USA
[9] Univ Cordoba, Reina Sofia Univ Hosp, Dept Med & Surg Sci, Rheumatol Serv,Maimonides Inst Res Biomed Cordoba, Cordoba, Spain
[10] Univ Laval, Ctr ARThr, CHU Quebec, Quebec City, PQ, Canada
[11] Univ Milan, Milan, Italy
[12] Univ Estado Rio de Janeiro, Rio De Janeiro, Brazil
[13] Hokkaido Univ Hosp, Sapporo, Japan
[14] Peking Univ First Hosp, Beijing, Peoples R China
[15] UCL, London, England
[16] Univ Utah, Salt Lake City, UT USA
[17] Intermt Healthcare, Salt Lake City, UT USA
[18] Univ Brescia, Brescia, Italy
[19] Hosp Univ 12 Octubre, Madrid, Spain
[20] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[21] Univ Barcelona, Hosp Clin, Dept Autoimmune Dis, IDIBAPS, Barcelona, Catalonia, Spain
[22] Univ Michigan, Ann Arbor, MI USA
[23] Istanbul Univ, Sch Med, Istanbul, Turkiye
[24] Univ Texas Med Branch, Galveston, TX USA
[25] Kings Coll London, Sch Cardiovasc & Metab Med & Sci, London, England
[26] Hosp Special Surg, Barbara Volcker Ctr Women & Rheumat Dis, Weill Cornell Med, New York, NY USA
关键词
antinuclear antibodies; antiphospholipid antibodies; antiphospholipid syndrome; phenotyping; MANIFESTATIONS; CRITERIA; UPDATE; COHORT;
D O I
10.1093/rheumatology/keae583
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: This study focused on the prevalence and impact of ANA in aPL-positive patients without concomitant systemic autoimmune rheumatic diseases (SARDs). Methods: Data from aPL-positive patients with or without Revised Sapporo APS classification criteria were retrieved from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Registry. Patients with concomitant SARDs were excluded. Results: A total of 430 aPL-positive patients were included in the analysis, 56% ANA-positive (ANA+) and 44% ANA-negative (ANA-). ANA positivity was significantly associated with history of haematologic manifestations (persistent autoimmune haemolytic anaemia, thrombocytopenia, leukopenia and/or lymphopenia) (16% of ANA+ vs 7% of ANA-, P = 0.006). Triple aPL-positivity was more frequent in the ANA+ subgroup (P = 0.02), along with low baseline C3 and C4 levels (P = 0.05 and P = 0.009, respectively), and higher frequency for ENA. Among aPLpositive patients with no APS classification, ANA+ patients showed a higher rate of arthritis (P = 0.006). Among female patients who have experienced at least one pregnancy, 113 were ANA+ and 96 were ANA-; ANA- patients had a higher number of pregnancies (P = 0.018), and number of live births (P = 0.014). A wider proportion of ANA+ patients were treated with HCQ (P < 0.001). Conclusion: When we analysed aPL-positive patients with no other SARDs, ANA status was not associated with thrombosis or pregnancy morbidity. Interestingly, ANA+ patients showed higher rates of systemic autoimmune features, including haematologic manifestations, multiple aPL positivity, lower complement levels, ENA positivity, and joint involvement, and were more often treated with HCQ. Finally, aPL-positive subjects who were ANA- had a higher rate of pregnancies and live births.
引用
收藏
页数:6
相关论文
共 22 条
  • [1] Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry")
    Erton, Zeynep B.
    Leaf, Rebecca K.
    de Andrade, Danieli
    Clarke, Ann E.
    Tektonidou, Maria G.
    Pengo, Vittorio
    Sciascia, Savino
    Ugarte, Amaia
    Belmont, H. Michael
    Gerosa, Maria
    Fortin, Paul R.
    Lopez-Pedrera, Chary
    Atsumi, Tatsuya
    Zhang, Zhouli
    Cohen, Hannah
    de Jesus, Guilherme Ramires
    Branch, David W.
    Wahl, Denis
    Andreoli, Laura
    Rodriguez-Almaraz, Esther
    Petri, Michelle
    Barilaro, Giuseppe
    Zuo, Yu
    Artim-Esen, Bahar
    Willis, Rohan
    Quintana, Rosana
    Vendramini, Margarete B. G.
    Barber, Megan W.
    Bertolaccini, Maria L.
    Roubey, Robert
    Erkan, Doruk
    LUPUS, 2022, 31 (14) : 1770 - 1776
  • [2] Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ('Registry')
    Erton, Zeynep Belce
    Sevim, Ecem
    de Jesus, Guilherme Ramires
    Cervera, Ricard
    Ji, Lanlan
    Pengo, Vittorio
    Ugarte, Amaia
    Andrade, Danieli
    Andreoli, Laura
    Atsumi, Tatsuya
    Fortin, Paul R.
    Gerosa, Maria
    Zuo, Yu
    Petri, Michelle
    Sciascia, Savino
    Tektonidou, Maria G.
    Aguirre-Zamorano, Maria Angeles
    Branch, D. Ware
    Erkan, Doruk
    LUPUS SCIENCE & MEDICINE, 2022, 9 (01):
  • [3] The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository
    Unlu, Ozan
    Erkan, Doruk
    Barbhaiya, Medha
    Andrade, Danieli
    Nascimento, Iana
    Rosa, Renata
    Banzato, Alessandra
    Pengo, Vittorio
    Ugarte, Amaia
    Gerosa, Maria
    Ji, Lanlan
    Efthymiou, Maria
    Ware Branch, D.
    de Jesus, Guilherme Ramires
    Tincani, Angela
    Michael Belmont, H.
    Fortin, Paul R.
    Petri, Michelle
    Rodriguez, Esther
    Pons-Estel, Guillermo J.
    Knight, Jason S.
    Atsumi, Tatsuya
    Willis, Rohan
    Zuily, Stephane
    Tektonidou, Maria G.
    ARTHRITIS CARE & RESEARCH, 2019, 71 (01) : 134 - 141
  • [4] Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository
    Lopes, Erivelton de Azevedo
    Moreira Balbi, Gustavo Guimaraes
    Tektonidou, Maria G.
    Pengo, Vittorio
    Sciascia, Savino
    Ugarte, Amaia
    Belmont, H. Michael
    Gerosa, Maria
    Fortin, Paul R.
    Lopez-Pedrera, Chary
    Ji, Lanlan
    Cohen, Hannah
    de Jesus, Guilherme Ramires
    Branch, D. Ware
    Nalli, Cecilia
    Petri, Michelle
    Rodriguez, Esther
    Kello, Nina
    Rios-Garces, Roberto
    Knight, Jason S.
    Atsumi, Tatsuya
    Willis, Rohan
    Bertolaccini, Maria Laura
    Erkan, Doruk
    Andrade, Danieli
    ADVANCES IN RHEUMATOLOGY, 2021, 61 (01)
  • [5] The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis
    Sciascia, Savino
    Willis, Rohan
    Pengo, Vittorio
    Krilis, Steve
    Andrade, Danieli
    Tektonidou, Maria G.
    Ugarte, Amaia
    Chighizola, Cecilia
    Branch, D. Ware
    Levy, Roger A.
    Nalli, Cecilia
    Fortin, Paul R.
    Petri, Michelle
    Rodriguez, Esther
    Rodriguez-Pinto, Ignasi
    Atsumi, Tatsuya
    Nascimento, Iana
    Rosa, Renata
    Banzato, Alessandra
    Erkan, Doruk
    Cohen, Hannah
    Efthymiou, Maria
    Mackie, Ian
    Bertolaccini, Maria Laura
    THROMBOSIS RESEARCH, 2019, 175 : 32 - 36
  • [6] Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository
    Erivelton de Azevedo Lopes
    Gustavo Guimarães Moreira Balbi
    Maria G. Tektonidou
    Vittorio Pengo
    Savino Sciascia
    Amaia Ugarte
    H. Michael Belmont
    Maria Gerosa
    Paul R. Fortin
    Chary Lopez-Pedrera
    Lanlan Ji
    Hannah Cohen
    Guilherme Ramires de Jesús
    D. Ware Branch
    Cecilia Nalli
    Michelle Petri
    Esther Rodriguez
    Nina Kello
    Roberto Ríos-Garcés
    Jason S. Knight
    Tatsuya Atsumi
    Rohan Willis
    Maria Laura Bertolaccini
    Doruk Erkan
    Danieli Andrade
    Advances in Rheumatology, 61
  • [7] APS ACTION - AntiPhospholipid Syndrome Alliance For Clinical Trials and InternatiOnal Networking
    Erkan, D.
    Lockshin, M. D.
    LUPUS, 2012, 21 (07) : 695 - 698
  • [8] Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository
    Efthymiou, Maria
    Mackie, Ian J.
    Lane, Philip J.
    Andrade, Danieli
    Willis, Rohan
    Erkan, Doruk
    Sciascia, Savino
    Krillis, Steven
    Bison, Elisa
    Galhardo Vendramini, Margarete Borges
    Romay-Penabad, Zurina
    Qi, Miao
    Tektonidou, Maria
    Ugarte, Amaia
    Chighizola, Cecilia
    Belmont, H. Michael
    Aguirre, Maria Angeles
    Ji, Lanlan
    Branch, D. Ware
    de Jesus, Guilherme
    Fortin, Paul R.
    Andreoli, Laura
    Petri, Michelle
    Cervera, Ricard
    Rodriguez, Esther
    Knight, Jason S.
    Atsumi, Tatsuya
    Vega, Joann
    Sevim, Ecem
    Bertolaccini, Maria Laura
    Pengo, Vittorio
    Cohen, Hannah
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2019, 17 (12) : 2069 - 2080
  • [9] Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository ("Registry")
    Yelnik, Cecile M.
    Erton, Zeynep Belce
    Drumez, Elodie
    Cheildze, Dachi
    de Andrade, Danieli
    Clarke, Ann
    Tektonidou, Maria G.
    Sciascia, Savino
    Pardos-Gea, Jose
    Pengo, Vittorio
    Ruiz-Irastorza, Guillermo
    Belmont, H. Michael
    Pedrera, Chary Lopez
    Fortin, Paul R.
    Wahl, Denis
    Gerosa, Maria
    Kello, Nina
    Signorelli, Flavio
    Atsumi, Tatsuya
    Ji, Lanlan
    Efthymiou, Maria
    Branch, D. Ware
    Nalli, Cecilia
    Rodriguez-Almaraz, Esther
    Petri, Michelle
    Cervera, Ricard
    Shi, Hui
    Zuo, Yu
    Artim-Esen, Bahar
    Pons-Estel, Guillermo
    Willis, Rohan
    Barber, Megan R. W.
    Skeith, Leslie
    Bertolaccini, Maria Laura
    Cohen, Hannah
    Roubey, Robert
    Erkan, Doruk
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 65
  • [10] Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study
    Gkrouzman, Elena
    Willis, Rohan
    Andrade, Danieli
    Tektonidou, Maria G.
    Pengo, Vittorio
    Ruiz-Irastorza, Guillermo
    Belmont, H. Michael
    Fortin, Paul R.
    Gerosa, Maria
    Signorelli, Flavio
    Atsumi, Tatsuya
    Branch, D. Ware
    Nalli, Cecilia
    Rodriguez-Almaraz, Esther
    Petri, Michelle A.
    Cervera, Ricard
    Knight, Jason S.
    Efthymiou, Maria
    Cohen, Hannah
    Bertolaccini, Maria Laura
    Erkan, Doruk
    Roubey, Robert
    LABORATORY INVESTIGATION, 2023, 103 (06)